Chiarion Sileni, Vanna <br/><br/>
[Pembrolizumab for the treatment of melanoma: updates and perspectives.]  [electronic resource] 

 -  Recenti progressi in medicina  Dec 2017 
 - 528-531 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2038-1840 
<br/><br/><label>Standard No.: </label>10.1701/2829.28585  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Humans<br/>Immunotherapy--methods<br/>Melanoma--drug therapy<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Survival Rate